Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

556 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. Among authors: shepherd fa. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
[The International Association for the Study of Lung Cancer Staging Project. Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer].
Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P; International Staging Committee and Participating Institutions. Chansky K, et al. Zhongguo Fei Ai Za Zhi. 2010 Jan;13(1):9-18. doi: 10.3779/j.issn.1009-3419.2010.01.02. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20672697 Free PMC article. Chinese.
Correction: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC.
Santoro A, Pilar G, Tan DSW, Zugazagoitia J, Shepherd FA, Bearz A, Barlesi F, Kim TM, Overbeck TR, Felip E, Cai C, Eddy S, McCulloch T, Schaefer ES. Santoro A, et al. Among authors: shepherd fa. BMC Cancer. 2024 Nov 21;24(1):1436. doi: 10.1186/s12885-024-13210-9. BMC Cancer. 2024. PMID: 39574037 Free PMC article. No abstract available.
Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research.
Barghout SH, Meti N, Chotai S, Kim CJH, Patel D, Brown MC, Hueniken K, Zhan LJ, Raptis S, Al-Agha F, Deutschman C, Grant B, Pienkowski M, Moriarty P, de Almeida J, Goldstein DP, Bratman SV, Shepherd FA, Tsao MS, Freedman AN, Xu W, Liu G. Barghout SH, et al. Among authors: shepherd fa. Br J Cancer. 2024 Nov 21. doi: 10.1038/s41416-024-02899-x. Online ahead of print. Br J Cancer. 2024. PMID: 39572762 Review.
Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC.
Santoro A, Pilar G, Tan DSW, Zugazagoitia J, Shepherd FA, Bearz A, Barlesi F, Kim TM, Overbeck TR, Felip E, Cai C, Eddy S, McCulloch T, Schaefer ES. Santoro A, et al. Among authors: shepherd fa. BMC Cancer. 2024 Oct 24;24(1):1307. doi: 10.1186/s12885-024-12841-2. BMC Cancer. 2024. PMID: 39448966 Free PMC article. Clinical Trial.
Outcomes with non-small cell lung cancer and brain-only metastasis.
Schmid S, Garcia M, Zhan L, Cheng S, Khan K, Chowdhury M, Sabouhanian A, Herman J, Walia P, Strom E, Brown MC, Patel D, Xu W, Shepherd FA, Sacher AG, Leighl NB, Bradbury PA, Liu G, Shultz D. Schmid S, et al. Among authors: shepherd fa. Heliyon. 2024 Aug 29;10(17):e37082. doi: 10.1016/j.heliyon.2024.e37082. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39296139 Free PMC article.
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center Experience.
Kuang S, Chen K, Sayal S, Prabahan G, Rabey MR, Le LW, Seto A, Shepherd FA, Liu G, Bradbury P, Sacher AG, Law JH, Sabatini P, Stockley TL, Tsao MS, Leighl NB. Kuang S, et al. Among authors: shepherd fa. Curr Oncol. 2024 Aug 3;31(8):4476-4485. doi: 10.3390/curroncol31080334. Curr Oncol. 2024. PMID: 39195317 Free PMC article.
Treatment patterns and outcomes in KRASG12C-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study.
Barghout SH, Zhan LJ, Raptis S, Al-Agha F, Esfahanian N, Popovacki A, Kasymjanova G, Proulx-Rocray F, Chan SWS, Richardson M, Brown MC, Patel D, Dean ML, Navani V, Moore E, Carvery L, Yan E, Goldshtein D, Cleary-Gosine J, Gibson AJ, Hubley L, Balaratnam K, Ngo T, Gill A, Black M, Sacher A, Bradbury PA, Shepherd FA, Leighl N, Cheema P, Kuruvilla S, Agulnik J, Banerji S, Juergens R, Blais N, Cheung W, Wheatley-Price P, Liu G, Snow S. Barghout SH, et al. Among authors: shepherd fa. Lung Cancer. 2024 Aug;194:107898. doi: 10.1016/j.lungcan.2024.107898. Epub 2024 Jul 25. Lung Cancer. 2024. PMID: 39074423
Immediate Versus Deferred Systemic Therapy in Patients With Mesothelioma.
Schmid S, Zhan L, Garcia M, Dietrich K, Khan K, Chowdhury M, Herman M, Patel D, Zaeimi F, Leighl NB, Sacher A, Feld R, Shepherd FA, Donahoe L, de Perrot M, Cho BCJ, Liu G, Bradbury PA. Schmid S, et al. Among authors: shepherd fa. Clin Lung Cancer. 2024 Nov;25(7):e277-e285.e3. doi: 10.1016/j.cllc.2024.04.011. Epub 2024 Apr 20. Clin Lung Cancer. 2024. PMID: 38825405
Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort.
Li Y, Wong M, Zhan L, Corke L, Brown MC, Cheng S, Khan K, Balatnaram K, Chowdhury M, Sabouhanian A, Herman J, Walia P, Strom E, Patel D, García-Pardo M, Schmid S, Eng L, Sacher AG, Leighl N, Bradbury PA, Shepherd FA, Shultz D, Liu G. Li Y, et al. Among authors: shepherd fa. Lung Cancer. 2024 Jun;192:107823. doi: 10.1016/j.lungcan.2024.107823. Epub 2024 May 16. Lung Cancer. 2024. PMID: 38763103
556 results